SCHEDULE 13G/A: Suvretta Capital Management Reduces Stake in Erasca, Inc. Below 5% Threshold
Beneficial Ownership Report Amendment
Suvretta Capital Management, LLC, along with Averill Master Fund, Ltd. and Aaron Cowen, has filed an amended Schedule 13G indicating their beneficial ownership in Erasca, Inc. has fallen to 4.4% as of December 31, 2024.
Summary
- Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen collectively beneficially own 12,315,004 shares of Erasca, Inc. Common Stock.
- This represents 4.4% of the total outstanding shares of Erasca, Inc.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing where their beneficial ownership was likely above 5%.
- All reporting persons share both voting and dispositive power over the 12,315,004 shares.
- The event requiring this filing occurred on December 31, 2024, with the filing submitted on February 13, 2025.
- Suvretta Capital Management, LLC is organized in Delaware, Averill Master Fund, Ltd. in the Cayman Islands, and Aaron Cowen is a U.S. citizen.
- Aaron Cowen is identified as the control person for Suvretta Capital Management, LLC.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the implied reduction in a significant institutional investor's stake below the 5% reporting threshold, which can be interpreted as a decrease in confidence or a strategic divestment.
Negatives
- The filing indicates that Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen have reduced their beneficial ownership in Erasca, Inc. to below the 5% threshold, now holding 4.4% of the common stock. This implies a reduction from a previously reportable stake (likely above 5%), which can be interpreted as a negative signal by the market regarding the institutional investor's conviction.
Future Outlook
This document is a beneficial ownership report and does not contain forward-looking statements or guidance regarding the issuer's future performance or outlook.
Industry Context
This filing is a routine disclosure of institutional ownership changes, common across all industries. For the biotechnology or pharmaceutical sector, changes in significant institutional holdings can sometimes influence investor sentiment, particularly if a major fund reduces its stake, as it may signal a shift in investment strategy or outlook on the company's prospects.
Stakeholder Impact
- Shareholders: May interpret the reduction in institutional ownership as a negative signal, potentially influencing stock price.
- Investment Professionals: Will note the change in institutional holdings as part of their analysis of the company's investor base and market sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which required the filing of this statement (beneficial ownership change). |
| 02/13/2025 | Date the Schedule 13G Amendment No. 1 was filed with the SEC. |
Keywords
Erasca Inc., Suvretta Capital Management, Averill Master Fund, Aaron Cowen, Schedule 13G/A, Beneficial Ownership, Institutional Investor, Equity Stake, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.